Previous 10 | Next 10 |
Ekso Bionics Holdings (NASDAQ:EKSO) on Thursday announced the appointment of Jerome Wong as the company's interim chief financial officer, effective immediately. It comes after current CFO Jack Glenn resigned effective June 17, 2022 to pursue a new position at another public company. Won...
RICHMOND, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Jerome Wong as Interim Chief Financial Officer followi...
RICHMOND, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will present at the H.C. Wainwright Global Investment Conference taking place May 23-26...
The following slide deck was published by Ekso Bionics Holdings, Inc. in conjunction with this event. For further details see: Ekso Bionics (EKSO) Investor Presentation - Slideshow
Ekso Bionics Holdings, Inc. (EKSO) Q1 2022 Earnings Conference Call April 28, 2022 4:30 PM ET Company Participants Steven Sherman - Chairman & CEO Scott Davis - President & Chief Operating Officer Jack Glenn - CFO Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright D...
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2022. Rec...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Another day of investing awaits as we start it off with a breakdown of the biggest pre-market stock movers for Monday! Source: ventdusud / Shutterstock.com Moving stocks this morning is special dividend news, a manu...
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quart...
Ekso Bionics Holdings, Inc. (EKSO) Q4 2021 Results Earnings Conference Call February 25, 2022, 04:30 PM ET Company Participants Matt Steinberg - Investor Relations, Lazar Partners Steven Sherman - Chairman and Chief Executive Officer Scott Davis - President and Chief Operating Officer Bill Sh...
Ekso Bionics Holdings press release (NASDAQ:EKSO): Q4 GAAP EPS of -$0.23. Revenue of $4.1M (+82.2% Y/Y). Cash on hand at December 31, 2021 was $40.4 million, compared to $12.9 million at December 31, 2020. For further details see: Ekso Bionics Holdings GAAP EPS of -$0.23, revenue of $4....
News, Short Squeeze, Breakout and More Instantly...
Ekso Bionics Holdings Inc. Company Name:
EKSO Stock Symbol:
NASDAQ Market:
SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended...
HomeStreet Inc. (HMST) is expected to report $-0.06 for Q1 2024 Kforce Inc. (KFRC) is expected to report $0.58 for Q1 2024 Sun Communities Inc. (SUI) is expected to report $1.16 for Q1 2024 Mynaric AG (MYNA) is expected to report for Q4 2023 Albany International Corporation (AIN) ...
SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) (the "Company"), an industry leader in exoskele...